FDA — authorised 6 August 1984
- Marketing authorisation holder: DR REDDYS LABS INC
- Status: approved
🇺🇸 Augmentin 250 in United States
FDA authorised Augmentin 250 on 6 August 1984
Marketing authorisations
FDA — authorised 6 August 1984
- Application: NDA050575
- Marketing authorisation holder: US ANTIBIOTICS
- Local brand name: AUGMENTIN '250'
- Indication: FOR SUSPENSION — ORAL
- Status: approved
FDA — authorised 6 August 1984
- Application: NDA050564
- Marketing authorisation holder: US ANTIBIOTICS
- Local brand name: AUGMENTIN '250'
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 22 July 1985
- Application: NDA050597
- Marketing authorisation holder: US ANTIBIOTICS
- Local brand name: AUGMENTIN '250'
- Indication: TABLET, CHEWABLE — ORAL
- Status: approved
Augmentin 250 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Augmentin 250 approved in United States?
Yes. FDA authorised it on 6 August 1984; FDA authorised it on 6 August 1984; FDA authorised it on 6 August 1984.
Who is the marketing authorisation holder for Augmentin 250 in United States?
DR REDDYS LABS INC holds the US marketing authorisation.